TITLE

Pharmacokinetics of Digoxin: Interpreting Bioavailability

AUTHOR(S)
Sanchez, N.; Sheiner, L. B.; Halkin, H.; Melmon, K. L.
PUB. DATE
October 1973
SOURCE
British Medical Journal;10/20/1973, Vol. 4 Issue 5885, p132
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108560

 

Related Articles

  • The serum digoxin concentration: Ten questions to ask. Cauffield, Jacintha S.; Gums, John G. // American Family Physician;8/1/1997, Vol. 56 Issue 2, p495 

    Provides information on pharmacokinetics of serum digoxin concentration. Simplified interpretation of serum digoxin; Digoxin dosage forms and dosing recommendations; Clinically significant digoxin drug interactions.

  • Digitalis Glycosides. Doherty, James E. // Annals of Internal Medicine;Aug73, Vol. 79 Issue 2, p229 

    Discusses the pharmacokinetics of digitalis glycosides. Types of cardiac glycosides; Absorption, metabolism and excretion of digoxin; Major difference between digoxin and metabolite digoxin; Special problems of therapy.

  • Investigation of the interaction between argatroban and acetaminophen,lidocaine,or digoxin. Inglis, Anne Marie L.; Sheth, Sunita B.; Hursting, Marcie J.; Tenero, David M.; Graham, Alison M.; Dicicco, Robert A. // American Journal of Health-System Pharmacy;7/1/2002, Vol. 59 Issue 13, p1258 

    Explores the potential pharmacokinetic interactions between agratroban and acetaminophen, lidocaine or digoxin. lack of a pharmacokinetic interaction demonstrated in each study; No pharmacokinetic interaction detected between argatroban and acetaminophen, lidocaine or digoxin.

  • No Interaction between Hawthorn and Digoxin Suggested in Human Study. Brown, Donald J. // HerbalGram;Winter2004, Issue 61, p30 

    Studies the potential interactions and effects of hawthorn on the conventional cardiotonic drug digoxin's pharmacokinetic parameters. Blood collection for determination of digoxin renal clearance; Pharmacodynamic measurements.

  • Digitoxin Elimination Reduced During Quinidine Therapy. Garthy, Moshe; Sood, Paul; Rollins, Douglas E. // Annals of Internal Medicine;Jan81, Vol. 94 Issue 1, p35 

    Presents a study that examined the interaction between quinidine and digoxin. Pharmacokinetic values of digitoxin disposition with and without quinidine; Effect of quinidine on the distribution and elimination of digoxin; Characteristics of digitoxin.

  • The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. Eichelbaum, Michel; Greiner, Bernd; Fritz, Peter; Kreichgauer, Hans-Peter; Richter, Oliver von; Zundler, Johannes; Kroemer, Heyo K. // Journal of Clinical Investigation;8/15/2002, Vol. 110 Issue 4, p571 

    Discusses issues related to a study on the role of intestinal P-glycoprotein (P-gp) in the interaction of digoxin and rifampin. Relationship between intestinal P-gp and digoxin bioavailability; Concern regarding the calculation of oral digoxin bioavailability AUC.

  • Digoxin Tablet Bioavailability: Single-Dose and Steady-State Assessment. Preibisz, Jacek J.; Butler, Vincent P.; Lindenbaum, John // Annals of Internal Medicine;Oct74, Vol. 81 Issue 4, p469 

    Focuses on a study which tested the bioavailability of four lots of digoxin tablets with different dissolution rates. Subjects and method; Results; Discussion.

  • Influence of Digoxin Immune Fab Therapy and Renal Dysfunction on the Disposition of Total and Free Digoxin. Ujbelyi, Michael R.; Robert, Sylvie; Cummings, Doyle M.; Colucci, Robert D.; Green, Paul J.; Sailstad, Jeffrey; Vlasses, Peter H.; Zarowitz, Barbara J. // Annals of Internal Medicine;8/15/93, Vol. 119 Issue 4, p273 

    Features a study that characterized the disposition of total and free serum digoxin following the administration of digoxin Fab antibody in patients with varying degrees of renal function. Patient characteristics and laboratory values at admission; Pharmacokinetic parameters of free digoxin;...

  • Digitoxin-quinidine interaction: pharmacokinetic evaluation. Fenster, Paul E.; Powell, J. Robert; Graves, Penelope E.; Conrad, Kenneth A.; Hager, W. David; Goldman, Steven; Marcus, Frank I.; Fenster, P E; Powell, J R; Graves, P E; Conrad, K A; Hager, W D; Goldman, S; Marcus, F I // Annals of Internal Medicine;Nov80, Vol. 93 Issue 5, p698 

    The effect of quinidine on digitoxin single-dose pharmacokinetics was evaluated in five healthy adults. Blood was collected for 3 weeks, and a complete urine collection was obtained for 4 days, after a single intravenous dose of digitoxin. The protocol was conducted once while each subject was...

  • digoxin.  // Davis's Drug Guide for Nurses, 9th edition;2005, p303 

    Provides information on the drug digoxin. Therapeutic use; Pharmacokinetic actions; Side effects; Dosage; Effectiveness.

Share

Read the Article

Other Topics